Knowledge products

As consultants, much of our work is found in client reports, which may or may not be in the public domain. These knowledge products are the opportunity to make available Itad’s thinking and knowledge, collected from across our projects. There is a range of material here, including working papers, think pieces, academic articles, project publications, and webinars.

Pages: 1 2 3 4 10

Summary: Routes to Resilience: Insights from BRACED Year 1

BRACED is a unique programme, aiming to build resilience locally yet at scale in highly vulnerable places. To understand how BRACED is building climate and disaster resilience, the BRACED Knowledge Manager collates and synthesises evidence on how resilience is being built on the ground.

Summary: Routes to resilience: lessons from monitoring BRACED

To understand what does and does not work well in building climate and disaster resilience, the BRACED Knowledge Manager develops and tests a range of approaches and frameworks for measuring resilience.
During the first year of BRACED, we have:

Itad Summer 2016 Newsletter

Our Summer 2016 Newsletter looks back at the last 6 months here at Itad, including our recent reports and knowledge products, project highlights and an update from the Centre for Development Impact.

The Value of Evaluation: Tools for Budgeting and Valuing Evaluations

Itad’s Julian Barr and Rob Lloyd, with DFID’s David Rinnert, Danielle Dunne, and Anna Henttinen, with contributions from Bob Crabtree and Tom Wagstaff, explore the value of evaluation in this discussion paper.

How can capacity development promote evidence-informed policy making? – BCURE Evaluation Briefing No. 1

Itad is leading a three year impact evaluation of the £13 million UK Department for International Development (DFID) initiative ‘Building Capacity to Use Research Evidence Programme‘ (BCURE).
We are examining how and why different approaches to capacity building for evidence-informed …

Medicines Transparency Alliance (MeTA), Policy Briefing 1

Itad recently completed an evaluation of the Medicines Transparency Alliance (MeTA). This policy briefing provides a brief overview of the evaluation methods, findings, challenges and recommendations.

Pages: 1 2 3 4 10